Itraconazole and leishmaniasis: A randomised double-blind trial in cutaneous disease

International Journal for Parasitology

Volumn 26, Issue 12, 1996, Pages 1413-1415

  Dogra, Jaideep ^a,b   Saxena, V N ^c  

^a CGHS   (India)

^b Shivashakti C 11 ^*  (India)

^c S P MEDICAL COLLEGE   (India)

Author keywords

cutaneous leishmaniasis; India; itraconazole

Indexed keywords

ITRACONAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INDIA; LIVER FUNCTION; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS;

ANTIPROTOZOAL AGENTS; DOUBLE-BLIND METHOD; HUMANS; INDIA; ITRACONAZOLE; LEISHMANIASIS, CUTANEOUS; LIVER FUNCTION TESTS;

EID: 0030498119     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(96)00128-2     Document Type: Article

References (12)

1. Beach D. H., Holz G. G. & Anchiwe G. E. 1979. Lipids of Leishmania promastigotes. Journal of Parasitology 65: 203-216.
2. Berman J. D. 1981. Activity of imidazoles against Leishmania tropica in human macrophage cultures. American Journal of Tropical Medicine and Hygiene 30: 566-569.
3. Borelli D. 1987. A clinical trial of itraconazole in the treatment of deep mycosis and leishmaniasis. Reviews of Infectious Diseases 9(1): 57-63.
4. Borgers M. 1980. Mechanism of action of anti fungal drugs, with special reference to imidazole derivatives. Reviews of Infectious Diseases 2: 520-534.
5. Cauwenberg G., Degreef H., Heykants J., Woestenborghs R., van Rooy P. & Haeverans K. 1988. Pharmacokinetic profile of orally administered itraconazole in human skin. Journal of the American Academy of Dermatology 18: 263-268.
6. Desjeux P. 1992. Information on the Epidemiology and Control of Leishmaniasis by Country or Territory. W.H.O. & Geneva.
7. Dogra J. 1991. A double blind study on the efficacy of oral dapsone in cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hvgiene 85: 212-213.
8. Dogra J. 1992. Cutaneous leishmaniasis in India. Evaluation of oral drugs (dapsone versus itraconazole). European Journal of Dermatology 2: 568-569.
9. Dogra J. & Aneja N. 1994. Leishmaniasis and itraconazole. A controlled clinical trial on cutaneous subtypes. International Journal of Antimicrobial Agents 4: 309-311.
10. Dogra J., Aneja N., Lal B. B. & Misra S. N. 1990. Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R51211). International Journal of Dermatology 29: 661-662.
11. Hart D. T., Lauwers W. J., Willemsens G., Bossche H. V. & Opperdoes F. R. 1989. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Molecular and Biochemical Parasitology 33: 123-134.
12. Srivastava D., Vyas M. C. & Joshi C. K. 1987. Clinico epidemiological study of cutaneous leishmaniasis in Bikaner (Rajasthan). Journal of Communicable Diseases 19:326-331.